AI powered efficiency Faro focuses on AI-assisted protocol design and real-time insights to accelerate clinical study startup, presenting an opportunity to upsell workflow automation and data integration solutions to shorten timelines and reduce manual efforts.

Enterprise scale fit With 51-200 employees and a B2B software footprint, Faro likely seeks scalable, enterprise-grade solutions (security, governance, deployment in regulated environments) that can grow with multi-study programs and cross-functional teams.

Clinical workflow integration The platform connects design decisions to downstream workflows, suggesting value in expanding integration with EHRs, CTMS, and data lakes to further streamline study operations and ensure end-to-end traceability.

Global expansion signals Recent news indicates a broad, strategic pivot and potential new business units; this signals openness to partnerships, co-development, or channel partnerships to broaden market reach and accelerate adoption.

Financial and investment clues Revenue is mid-market scale with a notable funding round; this indicates readiness for value-driven ROI proposals, referenceable case studies, and highlighted ROI metrics to justify expansion into larger trials or new therapeutic areas.